Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 4,4x - 4,9x | 4,7x |
| Selected Fwd Revenue Multiple | 3,5x - 3,8x | 3,6x |
| Fair Value | ﷼51,69 - ﷼57,46 | ﷼54,57 |
| Upside | 10,2% - 22,5% | 16,4% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Mouwasat Medical Services Company | 4002 | SASE:4002 |
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Almoosa Health Company | 4018 | SASE:4018 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| Middle East Healthcare Company | 4009 | SASE:4009 |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 4017 | SASE:4017 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| 4002 | 4007 | 4018 | 4013 | 4009 | 4017 | |||
| SASE:4002 | SASE:4007 | SASE:4018 | SASE:4013 | SASE:4009 | SASE:4017 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 9.2% | 3.4% | NM- | 17.4% | 14.0% | 11.2% | ||
| 3Y CAGR | 10.3% | 6.6% | 19.7% | 15.6% | 15.5% | 12.4% | ||
| Latest Twelve Months | 6.4% | -1.9% | 22.8% | 17.8% | 8.7% | 20.0% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 27.9% | 21.3% | 12.2% | 20.3% | 8.3% | 15.7% | ||
| Prior Fiscal Year | 28.0% | 29.1% | 12.7% | 22.0% | 12.2% | 14.4% | ||
| Latest Fiscal Year | 25.1% | 26.5% | 15.1% | 21.0% | 15.3% | 12.9% | ||
| Latest Twelve Months | 25.1% | 26.5% | 15.1% | 21.0% | 15.3% | 12.9% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 5.06x | 5.47x | 6.41x | 9.56x | 2.86x | 4.12x | ||
| EV / LTM EBIT | 20.1x | 20.6x | 42.3x | 45.4x | 18.7x | 32.1x | ||
| Price / LTM Sales | 4.92x | 5.54x | 5.31x | 9.05x | 2.00x | 3.87x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 2.86x | 5.47x | 9.56x | |||||
| Historical EV / LTM Revenue | 4.12x | 4.12x | 4.12x | |||||
| Selected EV / LTM Revenue | 4.44x | 4.67x | 4.90x | |||||
| (x) LTM Revenue | 2,791 | 2,791 | 2,791 | |||||
| (=) Implied Enterprise Value | 12,378 | 13,029 | 13,681 | |||||
| (-) Non-shareholder Claims * | (723) | (723) | (723) | |||||
| (=) Equity Value | 11,655 | 12,307 | 12,958 | |||||
| (/) Shares Outstanding | 230.0 | 230.0 | 230.0 | |||||
| Implied Value Range | 50.67 | 53.51 | 56.34 | |||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 50.67 | 53.51 | 56.34 | 46.90 | ||||
| Upside / (Downside) | 8.0% | 14.1% | 20.1% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4002 | 4007 | 4018 | 4013 | 4009 | 4017 | |
| Enterprise Value | 14,575 | 6,316 | 7,695 | 106,607 | 8,172 | 11,510 | |
| (+) Cash & Short Term Investments | 512 | 245 | 38 | 2,891 | 52 | 534 | |
| (+) Investments & Other | 0 | 135 | 9 | 465 | 60 | 196 | |
| (-) Debt | (762) | (304) | (1,353) | (8,165) | (2,466) | (1,078) | |
| (-) Other Liabilities | (145) | 0 | 0 | (438) | (48) | (374) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 14,180 | 6,392 | 6,389 | 101,360 | 5,771 | 10,787 | |
| (/) Shares Outstanding | 200.0 | 160.0 | 44.3 | 350.0 | 92.0 | 230.0 | |
| Implied Stock Price | 70.90 | 39.95 | 144.20 | 289.60 | 62.70 | 46.90 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 70.90 | 39.95 | 144.20 | 289.60 | 62.70 | 46.90 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |